Hira Automobile Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 4, 2025, 1:13 am

Quick Insight

Hira Automobile Ltd currently trades at ₹390 with a market capitalization of ₹107 Cr and a high P/E ratio of 149, indicating an expensive valuation compared to the industry average of around 30-40x. The company's Return on Equity (ROE) stands at 5.76%, below the sector median of 10-15%, while the Return on Capital Employed (ROCE) at 8.95% is slightly better but still trails behind peers. With a low Operating Profit Margin (OPM) of 8.75% and a Price-to-Book Value (P/BV) ratio of 2.68x, investors may find the stock overvalued based on its current financial performance.

Despite these challenges, Hira Automobile Ltd boasts a robust promoter holding of 95.73% and a healthy Interest Coverage Ratio (ICR) of 1.29x, providing stability and a level of confidence in the company's management. However, the company's high level of borrowings at ₹83 Cr and a Cash Conversion Cycle (CCC) of 128 days pose significant risks, especially in a volatile market environment. Looking ahead, improving operational efficiency, reducing debt levels, and enhancing profitability through cost optimization measures could brighten the company's outlook, while failure to address these issues may exacerbate its current vulnerabilities and erode shareholder value.

In conclusion, while Hira Automobile Ltd exhibits strengths in promoter ownership and interest coverage, its heavy reliance on borrowings and subpar financial ratios signal caution for potential investors. Monitoring the company's progress in addressing its debt burden and enhancing operational performance will be crucial in determining its future trajectory in the competitive trading and distribution sector.

Competitors of Hira Automobile Ltd

All Competitor Stocks of Hira Automobile Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:45 pm

Below is a detailed analysis of the quarterly data for Hira Automobile Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 22.73 Cr.. The value appears to be declining and may need further review. It has decreased from 46.31 Cr. (Mar 2025) to 22.73 Cr., marking a decrease of 23.58 Cr..
• For Expenses, as of Jun 2025, the value is 20.74 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.21 Cr. (Mar 2025) to 20.74 Cr., marking a decrease of 23.47 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.99 Cr.. The value appears to be declining and may need further review. It has decreased from 2.10 Cr. (Mar 2025) to 1.99 Cr., marking a decrease of 0.11 Cr..
• For OPM %, as of Jun 2025, the value is 8.75%. The value appears strong and on an upward trend. It has increased from 4.53% (Mar 2025) to 8.75%, marking an increase of 4.22%.
• For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.24 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.22 Cr..
• For Interest, as of Jun 2025, the value is 1.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.94 Cr. (Mar 2025) to 1.63 Cr., marking a decrease of 0.31 Cr..
• For Depreciation, as of Jun 2025, the value is 0.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.32 Cr., marking an increase of 0.05 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.07 Cr..
• For Tax %, as of Jun 2025, the value is 16.67%. The value appears to be increasing, which may not be favorable. It has increased from -15.38% (Mar 2025) to 16.67%, marking an increase of 32.05%.
• For Net Profit, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.15 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.10 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.18. The value appears to be declining and may need further review. It has decreased from 0.54 (Mar 2025) to 0.18, marking a decrease of 0.36.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:56 pm

Balance Sheet

Last Updated: September 10, 2025, 3:52 pm

Below is a detailed analysis of the balance sheet data for Hira Automobile Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Borrowings, as of Mar 2025, the value is 83.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 82.00 Cr. (Mar 2024) to 83.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 105.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 101.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 4.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 88.00 Cr. (Mar 2024) to 90.00 Cr., marking an increase of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 4.00 Cr..

However, the Borrowings (83.00 Cr.) are higher than the Reserves (12.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hira Automobile Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 5. It has increased from 2.46 (Mar 24) to 2.84, marking an increase of 0.38.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 5. It has increased from 2.46 (Mar 24) to 2.84, marking an increase of 0.38.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.46. This value is within the healthy range. It has increased from 7.33 (Mar 24) to 7.46, marking an increase of 0.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.52. It has increased from 49.69 (Mar 24) to 52.52, marking an increase of 2.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.52. It has increased from 49.69 (Mar 24) to 52.52, marking an increase of 2.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 767.07. It has decreased from 952.36 (Mar 24) to 767.07, marking a decrease of 185.29.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 36.35. This value is within the healthy range. It has decreased from 37.66 (Mar 24) to 36.35, marking a decrease of 1.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is 31.73. This value is within the healthy range. It has decreased from 32.79 (Mar 24) to 31.73, marking a decrease of 1.06.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.53. This value is within the healthy range. It has decreased from 4.49 (Mar 24) to 3.53, marking a decrease of 0.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.84. This value is within the healthy range. It has increased from 2.46 (Mar 24) to 2.84, marking an increase of 0.38.
• For PBDIT Margin (%), as of Mar 25, the value is 4.73. This value is below the healthy minimum of 10. It has increased from 3.95 (Mar 24) to 4.73, marking an increase of 0.78.
• For PBIT Margin (%), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 10. It has increased from 3.44 (Mar 24) to 4.13, marking an increase of 0.69.
• For PBT Margin (%), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 10. It has decreased from 0.47 (Mar 24) to 0.45, marking a decrease of 0.02.
• For Net Profit Margin (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 5. It has increased from 0.25 (Mar 24) to 0.36, marking an increase of 0.11.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.40. This value is below the healthy minimum of 15. It has increased from 4.95 (Mar 24) to 5.40, marking an increase of 0.45.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.30. This value is within the healthy range. It has increased from 20.23 (Mar 24) to 20.30, marking an increase of 0.07.
• For Return On Assets (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from 0.66 (Mar 24) to 0.74, marking an increase of 0.08.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.76. This value exceeds the healthy maximum of 1. It has decreased from 2.03 (Mar 24) to 1.76, marking a decrease of 0.27.
• For Total Debt / Equity (X), as of Mar 25, the value is 5.72. This value exceeds the healthy maximum of 1. It has decreased from 5.74 (Mar 24) to 5.72, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.04. It has decreased from 2.66 (Mar 24) to 2.04, marking a decrease of 0.62.
• For Current Ratio (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 1.5. It has decreased from 1.55 (Mar 24) to 1.43, marking a decrease of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.73, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 3. It has decreased from 1.33 (Mar 24) to 1.29, marking a decrease of 0.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 3. It has increased from 1.09 (Mar 24) to 1.10, marking an increase of 0.01.
• For Enterprise Value (Cr.), as of Mar 25, the value is 116.57. It has increased from 85.83 (Mar 24) to 116.57, marking an increase of 30.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.55, marking an increase of 0.23.
• For EV / EBITDA (X), as of Mar 25, the value is 11.65. This value is within the healthy range. It has increased from 8.28 (Mar 24) to 11.65, marking an increase of 3.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has increased from 0.04 (Mar 24) to 0.18, marking an increase of 0.14.
• For Price / BV (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 0.81 (Mar 24) to 2.68, marking an increase of 1.87.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has increased from 0.04 (Mar 24) to 0.18, marking an increase of 0.14.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness